United states to approve potent oral drugs for hepatitis c

Improved treatments offer hope for eradication of viral liver infection. Access through your institution Buy or subscribe This is a preview of subscription content, access via your

institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 51 print issues and online access $199.00 per year only $3.90 per issue Learn more Buy this

article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in

* Learn about institutional subscriptions * Read our FAQs * Contact customer support Authors * Sara Reardon View author publications You can also search for this author inPubMed Google

Scholar RELATED LINKS RELATED LINKS RELATED LINKS IN NATURE RESEARCH All-oral HCV therapies near approval 2013-May-31 Targeted drugs to tackle hepatitis C 2013-May-01 New drug targets raise

hopes for hepatitis C cure 2011-Apr-26 RELATED EXTERNAL LINKS The Liver Meeting 2013, 64th Annual Meeting of the AASLD RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE

THIS ARTICLE Reardon, S. United States to approve potent oral drugs for hepatitis C. _Nature_ (2013). https://doi.org/10.1038/nature.2013.14059 Download citation * Published: 30 October

2013 * DOI: https://doi.org/10.1038/nature.2013.14059 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable

link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative